Oritavancin News
Most Popular Oritavancin Story
FDA: Targanta must conduct new oritavancin study
In a complete response letter the FDA informed Targanta Therapeutics that it will have to conduct another study of oritavancin, the company's experimental antibiotic for complicated skin and skin Read more...
Latest Headlines
- January 13, 2009
- December 19, 2008
- December 9, 2008
- November 20, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
